A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma.
EBioMedicine
; 102: 105090, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-38547578
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoma
/
Triazines
/
Bone Neoplasms
/
Chondrosarcoma
/
Aminopyridines
Limits:
Animals
/
Humans
Language:
En
Journal:
EBioMedicine
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: